The device involved in this mdr report is not approved in the united states; however, it is similar to a device manufactured by microport crm that was cleared or approved by fda for marketing in the united states.Review of the episodes recorded in the patient files dated on (b)(6) 2022 showed that several treated arrhythmia episodes were recorded.The 2 reported arrythmia episodes, on (b)(6) 2022, were treated by atp.On these 2 episodes, the ventricular rhythm was accelerated < 315ms (314ms on both cases) and stable.Thus, according to the programming, atp was delivered.Based on the available information, the algorithm / icd functioned according to specifications.
|